https://www.syndivia.com/news daily 0.75 2025-11-14 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518466630374-Y1P29Z8YLPB4934O5C8D/red_small.png News https://www.syndivia.com/news/gsk-acquires-exclusive-rights-from-syndivia-for-antibody-drug-conjugate-adc-in-prostate-cancer monthly 0.5 2025-10-28 https://www.syndivia.com/news/syndivia-to-present-preclinical-data-at-american-association-for-cancer-research-aacr-annual-meeting-2025 monthly 0.5 2025-10-17 https://www.syndivia.com/news/syndivia-and-university-of-strasbourg-reveal-novel-conjugation-strategy monthly 0.5 2025-10-17 https://www.syndivia.com/news/syndivia-presents-new-dar1-adc-data-at-the-antibody-industrial-symposium monthly 0.5 2025-11-14 https://www.syndivia.com/news/syndivias-geminimab-wins-best-drug-based-innovation-award-from-matwin-board-arjpm monthly 0.5 2025-11-14 https://www.syndivia.com/news/syndivia-unveils-new-geminimab-site-specific-conjugation-technology-at-world-adc-london-2024 monthly 0.5 2025-11-14 https://www.syndivia.com/news/syndivia-unveils-new-clinical-asset-featuring-proprietary-adc-linker-technology monthly 0.5 2025-10-17 https://www.syndivia.com/news/renowned-nobel-laureate-jean-marie-lehn-appointed-chairman-of-syndivias-scientific-advisory-board monthly 0.5 2025-10-17 https://www.syndivia.com/news/syndivia-and-tvm-capital-life-science-announce-creation-of-auricula-biosciences-to-develop-innovative-therapy-for-patients-with-k-ras-mutant-malignancies monthly 0.5 2025-10-17 https://www.syndivia.com/news/syndivia-receives-2m-deeptech-financing-from-bpifrance-to-advance-its-lead-immunoconjugate-for-solid-cancers monthly 0.5 2025-10-17 https://www.syndivia.com/news/syndivia-in-licenses-darx-technology-for-dar1-adc monthly 0.5 2025-10-17 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/0c0e5aa4-ef6e-415a-bb91-f2239f853a96/adc_d1.png News - Syndivia In-Licenses DARx Technology for 1-to-1 Linkage of Antibodies and Payloads for Preparation of DAR1 ADC - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.syndivia.com/news/syndivia-in-licenses-novel-antibody-against-tumor-specific-form-of-cd146-from-satt-sud-est monthly 0.5 2025-10-17 https://www.syndivia.com/news/syndivia-raises-1m-investment-to-advance-its-tumour-microenvironment-drug-delivery-platform monthly 0.5 2025-10-17 https://www.syndivia.com/news/syndivia-is-a-laureate-astrazenecas-open-innovation-program-realize monthly 0.5 2025-10-17 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1570188772238-Y7780IFW0HB7ELWM9E4W/xrealize-saison2.png.pagespeed.ic.VhUZe9XiS0.png News - Syndivia is a laureate AstraZeneca's open innovation program - ReAliZe https://www.syndivia.com/news/syndivia-and-bfcl-publish-review-of-antibodyoligonucleotide-conjugates-aoc-as-therapeutic-imaging-and-detection-agents monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1564053925598-CZ6ZVGCFN3SUX5KVM956/toc_final.png News - Syndivia and BFCL publish review of Antibody–Oligonucleotide Conjugates (AOC) as therapeutic, imaging, and detection agents https://www.syndivia.com/news/meet-us-at-bio-2019 monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1563976222914-2HCB6Q3N1YXP0QL984ZM/BIO+CONVENTION+LOGO_HORIZONTAL_DA_RGB.png News - Meet us at BIO 2019 https://www.syndivia.com/news/meet-us-at-pegs-boston-2019 monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1554294610159-54G9JOO1B47EW1B6CVL1/posters+anounces+sdv+pegs+eu+2019-01.png News - Meet us at PEGS Boston 2019 https://www.syndivia.com/news/syndivias-cso-speaking-at-pegs-europe-2018 monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1538569619366-C3IOGXMN29PGMN9Q0CMS/pegs2018.png News - Syndivia's CSO speaking at PEGS Europe 2018 https://www.syndivia.com/news/meet-us-at-bio-europe-2018 monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1537359770324-G3ZD95WJ6RINQ70K2YAE/BE18-370x80-e9f25d957b03aed254bc9c987ef164ed.png News - Meet us at BIO Europe 2018 https://www.syndivia.com/news/syndivia-presenting-at-medfit-2018 monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1537361763049-6LW2LL5TDGGK3TCEXQYS/logo_medfit.jpg News - Syndivia presenting at MedFIT 2018 https://www.syndivia.com/news/syndivia-wins-the-2017-european-venture-contest-final monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518470819829-AHPJP7LZLAY5J9MCJHAI/evc.png News - Syndivia wins the 2017 European Venture Contest Final https://www.syndivia.com/news/syndivia-is-participating-in-the-world-adc-san-diego-2017 monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518470734333-162E57J657SAUD1C341W/2017-logo-e1477328850580_orig.png News - Syndivia is participating in the World ADC San Diego 2017 https://www.syndivia.com/news/syndivia-wins-the-france-tech-transfer-invest-award monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518470652726-CU3A186HHJJ8QXFI6TYG/showlogo-aspx_orig.png News - Syndivia wins the France Tech Transfer Invest Award https://www.syndivia.com/news/ogd2-pharma-and-syndivia-launch-collaboration-to-develop-an-adc-targeting-the-o-acetyl-gd2-cancer-antigen monthly 0.5 2025-09-30 https://www.syndivia.com/news/syndivia-receives-the-eus-horizon-2020-grant monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518470489590-6Y4WXNX520AU85VBOM4Q/flag-yellow-low.jpg News - Syndivia receives the EU’s Horizon 2020 grant https://www.syndivia.com/news/meet-us-at-the-smis-annual-adc-summit monthly 0.5 2025-09-30 https://www.syndivia.com/news/publication-in-bioconjugate-chemistry monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518469594457-YYEGSU93BHLEOEZ2PV89/1970467.png News - Publication in Bioconjugate Chemistry https://www.syndivia.com/news/syndivia-lands-275k-grant-to-develop-next-generation-targeted-cancer-therapies monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518469533040-8L2X766HNTKT5KTTDZQW/9838246.png News - Syndivia lands €275k grant to develop next-generation targeted cancer therapies https://www.syndivia.com/news/syndivia-is-among-the-top-100-smes-of-the-hello-tomorrow-challenge monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518469397441-9Z036A1PSDADU94PFDGB/4925767.png News - Syndivia is among the TOP 100 SMEs of the Hello Tomorrow Challenge https://www.syndivia.com/news/syndivia-is-granted-the-prestigious-matwin-label monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518469302398-QNC0M9A43U004V4JN5C8/3854579.jpg News - Syndivia is granted the prestigious MATWIN label https://www.syndivia.com/news/publication-in-chemical-society-reviews monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518469210604-TN50TAI2SPVNMKDI0KHF/6074430_orig.png News - Publication in Chemical Society Reviews https://www.syndivia.com/news/syndivia-is-a-finalist-of-onestart-2015 monthly 0.5 2025-09-30 https://www.syndivia.com/news/apn-technology-cbtf-linker-publication-in-bioconjugate-chemistry monthly 0.5 2025-09-30 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518468854347-RFFTX3JQWOTXGYBHFH99/4594650.png News - APN technology | CBTF linker | Publication in Bioconjugate Chemistry https://www.syndivia.com/news/syndivia-signs-a-licence-agreement-with-satt-conectus monthly 0.5 2025-09-30 https://www.syndivia.com/news/syndivia-laureate-of-prix-rgion-alsace monthly 0.5 2025-09-30 https://www.syndivia.com/news/syndivia-laureate-of-concours-national-daide-la-cration-dentreprises-innovantes monthly 0.5 2025-09-30 https://www.syndivia.com/syndivia daily 1.0 2026-01-29 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/405568e0-849c-4e39-931c-216bce86680a/GeminiMab-Schematics.webp https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/40426400-04b3-447f-a4bf-1acab5f09c46/optimal-dar.png https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518812556009-PYPHK6581FL7CDO5UUZ5/445A4268-web-800.jpg https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518813348637-ZUG4F5DI756O4Q3S3Z4Y/445A4240-web-800.jpg https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/b0f9172a-2ab6-4172-bc54-7f81f5380219/at https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/1518813384166-X9CNIOIBK83QLUK7UCGE/445A4256-web-800.jpg https://www.syndivia.com/dar1-adc daily 0.75 2025-11-14 https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/21d42609-9a63-4d17-a4d0-cb99c985bea7/gemini-dar1-2.png https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/f8d39c16-08b0-427f-ac0f-c37db0009679/High_dosing_DAR1_ADC.png https://images.squarespace-cdn.com/content/v1/5a817e380100274e1903fef4/ea8eb24c-a39c-4df3-9228-a5383f5d56c5/ADC_dual_mechanism_with_DAR1.png https://www.syndivia.com/faqs daily 0.75 2025-11-14